aktuell

The rising prevalence of salmonella infection is by far the leading factor driving the global Salmonella Testing Market. This infection generally affects the gastrointestinal tract of humans and animals, which may turn life threatening if left untreated for a long period. Contaminated food items such as infected meat, eggs, and unpasteurized milk and dairy products are the major source of transmission of the infection. Over the past few years, there have been several outbreaks of salmonella in the U.S. and in those occasions, many companies in the meat and dairy business had to recall their products from the market.

The commonly employed methods for the diagnosis of salmonella infection are stool culture method and real time PCR. In the former, stool of infected animal or human being is cultured, while the latter is done by intensifying and detecting targeted pathogen’s DNA sequence.

The research report is a professional study offering invaluable insights into various important parameters of the global salmonella testing market. It provides a comprehensive description of the factors influencing the market and the extent to which they impact the growth. For a coherent understanding, the report divides the market on the basis of several criteria including diagnosis method, food type, and geography. It includes tools such as market attractiveness analysis and Porter’s five force analysis to derive vendor landscape of the global salmonella testing market. It reviews the market for the period between 2016 and 2024.

The implementation of food safety regulations worldwide along with their increasing stringency is escalating the growth of the global salmonella testing market. The several incidents of outbreaks of salmonella have compelled governments and regulatory authorities across the world to keep a strict check on food products during every stage of their production and processing. Moreover, the rising awareness among consumers regarding foodborne diseases and rapid technological advancements in bacterial detection technologies are augmenting the market. On the other hand, the lack of proper food control resources and infrastructure in developing nations is hindering the growth of the market.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11507

The key segments analyzed in the report on the basis of geography are Asia Pacific, Europe, North America, and Rest of the World. North America will have a strong foothold in the market throughout the forecast period. The growth of the region is largely supplemented by the implementation of stringent food safety regulations, especially due to the high incidence of salmonella contamination. Moreover, rapid technological advancements in testing procedures and the presence of advanced healthcare infrastructure are contributing to the growth of the region.

Asia Pacific is expected to register a noteworthy CAGR during the review period. The improving healthcare facilities and growing research and development activities in the field of salmonella testing are propelling the growth of the region. The increasing prevalence of foodborne diseases is boosting the adoption of salmonella testing in the region. Countries such as India and China are estimated to be at the forefront of the growth of the region.

With the sharp rise in the demand for advanced testing methods, key players in the global salmonella testing market are pouring large funds into research and development activities to consolidate their presence. They are aiming at expanding their market shares through mergers and acquisitions. Some of the key players are operating in niche segments to gain an edge over competitors. While Life Technologies, Eiken Chemical Company Limited, Romer Labs, and Neogen Corporation are some of the prominent companies operating in the real-time PCR techniques, DuPont Qualicon and Hardy Diagnostics are among key players targeting culture detection methods.

Request to View ToC of the report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=11507

The field of biotechnology is presently one of the most researched and dynamically evolving areas of applied science. The field, dealing with the production of a variety of highly useful products from biological agents or their derivatives, has become a key complementary force, enabling proper operations and output across a number of industries. The applications of biotechnology and the vast range of products manufactured using its principles continue to rise at an enormous pace and the field is expected to witness expansion at a significant pace in the next few years as well.

This report on the global Biotechnology Instrumentation Market presents a detailed overview of the market that comprises services related to the basic and essential instrumentation utilizing a variety of equipment commonly used to measure, calculate, prepare, and utilize biological solutions/samples. Some of the most commonly used equipment in the field of biotechnology are thermal cyclers, bioreactors, centrifuges, incubators, stability chambers, conductivity meters, thermometers, and spectrophotometers.

The report presents a detailed analysis of the key factors expected to have a significant impact on the overall development of the market in the next few years, including, growth drivers, restraints, trends, opportunities, regulatory framework, and level of competition in the market. A detailed examination of the competitive landscape is also included in the report, undertaken with the help of a detailed Porter’s five forces analysis.

The global biotechnology instrumentation market witnessed significant traction in the past few years owing primarily to the vast rise in demand for biotechnology products for the production of personalized medicine. This emerging area of medicine, which aims to serve consumers through medicines produced by keeping in mind each individual’s biological makeup and eliminate the negative effects that could result from mass-produced medicines, is expected to be one of the key consumers of biotechnology products in the next few years.

With the vast rise in the prevalence of a variety of chronic diseases across the globe, the demand for personalized medicines is expected to rise at a significant pace in the next few years. This will also act as a significant growth factor for the global market for biotechnology instrumentation as a rapid surge is expected in the demand for human resources capable of serving the heightened demand for biotechnology products.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=167

The vast rise in the usage of 2D and 3D cell cultures in the field of discovery and manufacture of new drug compounds has also emerged as a key factor boosting the growth of the global biotechnology instrumentation market. A significant rise in research activities surrounding gene expression, especially since the inception of the Human Genome Project, has boosted the global demand for microarrays for studying the expression of genotype or gene clusters, propelling the global biotechnology instrumentation market.

North America and Europe are key markets for biotechnology instrumentation owing to the presence of a large number of some of the world’s largest biotechnology and pharmaceutical companies. The regions are also home to some of the leading universities continuously undertaking research in the field of gene expression, thus leading to vast growth opportunities for the biotechnology instrumentation market. In the next few years as well, these regions are expected to remain at the forefront of the global biotechnology instrumentation market, leading to vast development and growth opportunities for companies wanting to venture into this highly lucrative market.

Request to View ToC of the report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=167

Developing economies across regions such as Latin America and Asia Pacific are also expected to lead to vast growth opportunities for the market owing to the significant rise in research and development activities in the biotech sector. Research and development arms of several multinational pharmaceutical companies in these regions are also expected to drive the market.

The report details an exhaustive account of the global essential tremor treatment with ultrasound market along with numerous associated factors. Some of these factors that are included in the report are drivers, restraints, competitive analysis, latest trends and opportunities, geographical outlook, and many other aspects. The study covered in the report spans a forecast period from 2016 to 2024. From an overall perspective, the report is expected to exist as a valuable insight to businesses which are already operating in the global essential tremor treatment with ultrasound market, as well for those who intend to newly establish themselves in this environment.

Rapid technological advancements occurring in the field of medicine, mainly in the context of providing treatment for body tremors is majorly driving the global essential tremor treatment with ultrasound market to experience tremendous growth. Increasing number of cases of neurological disorders among people all over the world too is contributing towards an increase in revenue generated by this market. This is mainly due to body tremors being a common symptom that can occur in a person affected by a neurological disorder.

Moreover, with rising geriatric population, a notable prevalence of these diseases exists, thereby causing a high requirement of necessary equipment for treatment purposes. Favorable governmental initiatives in many economies such as FDA approvals for clinical trials, coupled with a silver lining existing for new players to enter the market also are a couple of prominent factors driving growth in the essential tremor treatment with ultrasound market. With rapidly advanced technology and better clinical outcomes, a rise in awareness among people regarding associated benefits too is a chief reason why the market is witnessing a good growth curve.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15353

However, mammoth costs required to set up procurement of ultrasound equipment and their accessories along with relevant technologies, as well as expensive research and development activities for the same is greatly hampering the market. Moreover, the possibility of other tissues getting damaged after using ultrasound techniques can also restrain the growth of the essential tremor treatment with ultrasound market. Lack of trained professionals in underdeveloped and remote areas who can use the ultrasound systems is another significant factor hindering the global essential tremor treatment with ultrasound market. Nevertheless, the picture is soon expected to change as numerous service provider companies are gradually introducing cost-regulated ultrasound tremor treatment techniques.

Geographically, this market is spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Of all these, North America is the winning regional segment of the global essential tremor treatment with ultrasound market, followed by Europe. Apart from these regions, Asia-Pacific also depicts an enhanced growth rate in the market during the forecast period. This is mainly attributed to the rise in geriatric population, an increase in incidences of neurological and cardiovascular diseases, extensive growth in healthcare expenditure, and rapidly growing healthcare industry in the region.

Request to View ToC of the report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=15353

Currently only one organization exists in this market that has a monopoly in the competitive landscape – InSightec Ltd. Owing to a monopoly, this company has gathered most of the shares generated in this market. Focusing on improving product portfolios, enhancing geographical reach, facilitating extensive research and development to manufacture quality treatment equipment, are key strategies implemented by the solo company present in the global essential tremor treatment with ultrasound market. However, market experts predict that in the near future, the number of players in this market could increase, thereby giving rise to a surge in the competition.

Viable tumor cells are widely used by scientists for in vitro studies about the genetic origins, molecular pathways of diseases such as cancer. The viable tumor samples are good examples of whole processed tissues which are widely used in basic oncology disease research as well as drug development. Studies on immune disorders are done only with viable tumor samples as these have unique characteristics such as these proliferate indefinitely when cultured (HeLa cell lines), no contact inhibition, abnormal karyotype, and simple media requirement. Viable tumor samples have limitless applications in research especially for autoimmune disorder and oncology research to detect cell markers, efficacy testing of drugs, and in providing insights into the physiological mechanisms of diseases.

Major market players in the global Viable Tumor Samples Market provide quality controlled viable tumor cells with correct analysis, ensure proper fixation, and confirm the tissue and tumor size. The global viable tumor samples market is driven by rising demand in the field of diagnosis and prognosis tests. Furthermore, huge application scope of viable tumor samples and worldwide use in therapeutic monitoring are anticipated to fuel the growth of the global viable tumor samples market. However, requirement of skilled professionals, high cost of development and maintenance of viable tumor samples, and stringent regulatory policies are expected to restrain the global viable tumor samples market.

The global viable tumor samples market has been segmented based on cancer type, method of storage, application, and end-user. In terms of cancer type, the global viable tumor samples market has been categorized into lung cancer, prostate cancer, breast cancer, liver cancer, carcinomas, sarcomas, melanomas, lymphomas, leukemia, and stem cells. Based on method of storage, the global viable tumor samples market has been divided into flash frozen tumor samples, fresh tumor samples, dissociated tumor cells, Formalin-Fixed, Paraffin Embedded (FPFE) method, and other special tumor sample processing methods.

Flash freezing treatments such as cryopreservation of viable tumor samples can store them till 10 years, hence are used more frequently. New methods such as Formalin-Fixed, Paraffin Embedded (FPFE) have certain advantages such as rapid and precise extraction of DNA. Hence, these are anticipated to show higher growth rate during the forecast period. In terms of application, the global viable tumor samples market has been segmented into drug testing along with drug target discovery, biomarker identification and/or validation, genetic studies including mutations, visualization of cell or tissue structure, studies related to cancer stem cells, and others. In terms of end-user, the global viable tumor samples market has been categorized into hospitals/clinics, diagnostic labs, research/academic institutes, cell banks, and others.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20852

Several market players are coming up with cutting edge technologies with mechanical as well as enzymatic approaches to increase the duration of viability along with quality controlled tumor size. Regulatory documentation of viable tissue samples with high quality of product is seen as emerging trend in the global viable tumor samples market. Increasing discoveries related to the unmet needs of oncology in terms of molecular pathways, drug invention, cancer metastasis blockers, etc. can create new opportunities in the global viable tumor samples market.

In terms of region, the global viable tumor samples market has been divided into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is expected to witness continual growth owing to increasing adoption of advanced therapeutic monitoring technologies. North America, followed by Europe, is expected to dominate the global viable tumor samples market due to new and technologically advanced products are introduced in the market and increasing specialty research initiatives. The global viable tumor samples market is estimated to experience high growth in pharma emerging regions as viable tumor samples are widely used during drug discovery in the preclinical testing of new drug candidates.

Request to View ToC of the report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=20852

Key players in the global viable tumor samples market are Conversant Bio, Miltenyi Biotec, Cureline, Inc., StoreMyTumor, Fluxion Biosciences, Crown Bioscience, Inc., and Indivumed GmbH, among others.

The global Ingestible Smart Pills Market is growing at a healthy pace in the last few years, thanks to the growing emphasis of the key players on the research and development activities. Moreover, the key players in the market are focusing on the expansion of the product portfolio, which is estimated to generate potential growth opportunities throughout the forecast period.

The research study on the global ingestible smart pills market offers a detailed analysis, highlighting the major factors that are expected to encourage the growth of the market in the next few years. In addition to this, the key segmentation, growth factors, opportunities, and the trends in the global ingestible smart pills market have been discussed thoroughly in the scope of the study.

The rising geriatric population and the rapid development of the healthcare facilities are the major factors that are projected to encourage the growth of the global ingestible smart pills market in the next few years. Innovations and technological developments in this field are also estimated to support the growth of the overall market. In addition to this, the willingness of patients to spend more on healthcare facilities, especially in developing economies are projected to enhance the growth of the global ingestible smart pills market in the near future.

The leading players in the global ingestible smart pills market are making notable efforts to create an awareness among patients regarding the availability and advantages of ingestible smart pills, which is likely to encourage the growth of the market. Moreover, the noticeable shift of patients from hospitals to home care and the growing demand for smart pills, thanks to its advanced features are projected to accelerate the market growth throughout the forecast period.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49593

The global ingestible smart pills market has been categorized on the basis of geography into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In the last few years, North America held a major share of the market and is likely to maintain its dominance in the coming few years. The presence of advanced healthcare facilities and the rising research activities are projected to accelerate the growth of the North America market in the near future. Furthermore, Asia Pacific is expected to register promising growth in the near future, owing to the rapid development of the healthcare facilities.

The global market for ingestible smart pills is at a developing stage and is projected to witness a high growth throughout the forecast period. The presence of a large number of players and the growing focus on the research and development activities are predicted to enhance the competitive landscape of the market in the near future. Some of the key players operating in the global ingestible smart pills market are Medimetrics, Olympus Corporation, CapsoVision, Inc., Given Imaging Ltd., Check-Cap Ltd., IntroMedic Co., Ltd., Philips Respironics, Proteus Digital Health, Inc., Chongqing Jinshan Science and Component (Group) Co., Ltd., and BodyCap-Medical.

Request to View ToC of the report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=49593

The global Regenerative Therapies Market is foretold to rise with high demand for therapeutic treatments. Strong government support for the treatment of chronic diseases in some parts of the world could promise growth opportunities to the global market. Substantial investments for building commercialization centers, manufacturing infrastructure, research networks, and centers of excellence are anticipated to indirectly benefit the global regenerative therapies market. The growth of the global regenerative therapies market could gain a boost as the demand for stem and tissue cell research technologies increases. Products developed using these technologies are used to treat chronic ailments with no permanent cure.

The global regenerative therapies market could be classified according to end user, application, and type of tissue. By end user, the market could be further segregated into educational institutes, ambulatory surgical centers, and hospitals.

This report provides a catholic evaluation of the global regenerative therapies market based on market competition, segmentation, and dynamics. It sheds light on how the global market could shape in the foreseeable future.

The rising trend of producing medicines using the human body’s own stem cells and tissues is predicted work in the favor of the global regenerative therapies market. A number of pharmaceutical companies are shifting from manufacturing synthetic drugs to regenerative therapy drugs. Though at an early stage of commercialization, the global regenerative therapies market could provide a whole lot of rewarding prospects to manufacturers as private firms, regional governing bodies, and governments make heavy investments. The global market is prognosticated to find improved growth with the rising use of products in the treatment of ocular, autoimmune, cardiovascular, neurological, orthopedic, and rare diseases.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49575

Benefits such as safer results and long-term effectiveness are prophesied to increase the demand for regenerative therapies in the near future. High demand for faster treatments and urgency in fulfilling unmet medical needs could up the growth of the global regenerative therapies market during the forecast period 2018-2026.

North America is envisaged to lead the global regenerative therapies market while accounting for a sizable share in the next few years. Development of new clinical infrastructure could augur well for the North America regenerative therapies market. Supportive legislations for regenerative therapies in the U.S. and Canada are projected to cause a surge in demand. Furthermore, high penetration of tissue banks in the region could push the growth of the market in North America.

On the other hand, Asia Pacific is forecast to log a higher CAGR on the basis of revenue. However, the MEA could show sluggish growth in the global regenerative therapies market due to the lack of suitable regulations to arrest the rise of illegitimate and untested practices in the field.

Request to View ToC of the report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=49575

The global regenerative therapies market marks the presence of leading players such as Organovo Holdings Inc., Astellas Pharma U.S., Inc., Nuo Therapeutics, Inc., Mesoblast Ltd., and Acelity L.P. Inc.

Chronic diseases are long-term clinical conditions that progress over the time. It is considered an expensive and most prevalent health care issue across the globe. Chronic disease management programs, thus, is an organized and proactive set of interventions that focuses on needs of the patient population. Chronic disease management involves the efforts taken by a defined set of patients and various health care professionals to improve health outcomes and the quality of life of patients. Improving the adherence of patients to chronic disease management is a key component. The plan of chronic disease management includes providing support from various medical and allied health services.

Integration of digital technologies with health care systems in developed countries, rising awareness about the seriousness of chronic and life-threatening diseases, and increasing healthcare expenditure of people are expected to drive the global chronic disease management market during the forecast period. However, lack of adherence and non-compliance of patients to the treatment plan, resulting into poor outcomes, is a key restraint for the global chronic disease management market from 2018 to 2026.

The global Chronic Disease Management Market has been segmented in terms of disease type, service type, delivery mode, and end-user. Based on disease type, the global chronic disease management market has been categorized into chronic obstructive pulmonary disease (COPD), asthma, diabetes, arthritis, heart diseases, and others. The heart diseases segment accounted for the highest market share in 2017, in terms of value. This is attributable to significantly high prevalence of heart diseases in developed countries and lifestyle changes.

However, increasing rate of obesity and sedentary lifestyle is propelling the number of patients suffering from diabetes, which is projected to boost the diabetes segment growth between 2018 and 2026. In terms of delivery mode, the global chronic disease management market has been divided into web-based, cloud-based, and on-premise. Increase in medical tourism in developing countries was a key factor responsible for the dominant share held by the on-premise segment in 2017. However, growth of the health care IT sector across the globe and rising investments by various players in the health care infrastructure are expected to augment the web-based segment from 2018 to 2026.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45057

Based on service type, the chronic disease management market can be divided into consulting service, educational services, implementation services, and others. The implementation services segment generated the maximum revenue in 2017, owing to emergence of numerous local service providers across the globe and their focus on providing efficient and cost-effective services to patients. Improved reimbursement policies by healthcare payers are expected to boost the segment during the forecast period. In terms of end-user, the chronic disease management market has been classified into healthcare providers and healthcare payers. Healthcare providers was the leading segment in terms of revenue in 2017, due to efforts taken by healthcare providers on non-compliant patients and on providing a comprehensive treatment plan and educational services to patients. The segment is anticipated to dominate the chronic disease management market between 2018 and 2026.

Geographically, the global chronic disease management market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the highest share of the global market in 2017, which is attributable to the rising demand of patients for cost-effective disease management and increasing prevalence of chronic diseases such as heart diseases and asthma in the U.S. and Canada. Europe is projected to be the second-most prominent market for chronic disease management during the forecast period, owing to improved accessibility of various chronic disease management programs. However, government participation in the prevention and control of life-threatening diseases in developing economies of Asia Pacific and significant investment by key players in China and India for betterment of healthcare infrastructure in these countries are expected to boost the market in Asia Pacific from 2018 to 2026.

Request to View ToC of the report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=45057

Prominent players operating in the global chronic disease management market are Allscripts Healthcare Solutions, Inc., ScienceSoft USA Corporation, Pegasystems Inc., Infosys Limited, TriZetto Corporation, MINES & Associates, Inc., Siemens Healthcare Private Limited, Harmony Information Systems, Inc., Phytel Inc., EXL Healthcare, Wellcentive, Inc., and HealthSmart Holdings, Inc.